# IL-2 for Multi Drug Resistant Nephrotic Syndrome

> **NCT02455908** · PHASE1,PHASE2 · COMPLETED · sponsor: **Istituto Giannina Gaslini** · enrollment: 5 (actual)

## Conditions studied

- Nephrotic Syndrome

## Interventions

- **DRUG:** Proleukin®

## Key facts

- **NCT ID:** NCT02455908
- **Lead sponsor:** Istituto Giannina Gaslini
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2015-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02455908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02455908, "IL-2 for Multi Drug Resistant Nephrotic Syndrome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02455908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*